The ex vivo effect of preadsorbed vitronectin on platelet activation.
The activation of ex vivo canine platelets by preadsorbed vitronectin (VN) was sensitive not only to the polymer substrate utilized but also to the adsorption conditions employed. Lower levels of maximal platelet deposition were obtained for VN-coated silicone rubber (SR) than for other VN-coated substrates with comparable levels of adsorbed VN, but this effect was diminished with increased residence time of VN on the SR surface. Submonolayer and monolayer surface concentrations of VN elicited similar maximal levels of platelet deposition at both short (less than 3 h) and long (greater than 12 h) residence times, but thrombi were larger and more dense for the submonolayer surface concentrations. VN was also more effective in forming thrombi when adsorbed sequentially before albumin instead of after albumin. To further examine these differences in the nature of adsorbed VN between substrates and adsorption conditions, sodium dodecyl sulfate (SDS) elutability measurements and Fourier transform infrared spectroscopy with attenuated total reflectance optics (FTIR-ATR) evaluations of the adsorbed protein were performed. An SDS solution was able to remove a greater percentage of the VN which was adsorbed to a submonolayer than a monolayer surface concentration when SDS displacement was initiated immediately after adsorption was terminated. However, if the adsorbed protein was allowed to reside on the surface for a length of time before the introduction of the SDS displacing media, a greater percentage of the monolayer surface concentration was removed. The submonolayer surface concentration may be better able to increase its strength of contact with the surface during the added residence time than the monolayer surface concentration.(ABSTRACT TRUNCATED AT 250 WORDS)
Fabrizius-Homan
D J
DJ
Department of Chemical Engineering, University of Wisconsin-Madison 53706.
Cooper
S L
SL
Mosher
D F
DF
D000327:Adsorption; D000818:Animals; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D004285:Dogs; D006023:Glycoproteins / Q000493:pharmacokinetics / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D008855:Microscopy, Electron, Scanning; D015539:Platelet Activation / Q000187:drug effects*; D011108:Polymers; D012709:Serum Albumin / Q000493:pharmacokinetics; D012826:Silicone Elastomers; D013055:Spectrophotometry, Infrared; D013499:Surface Properties; D019096:Vitronectin
D006023:Glycoproteins; D011108:Polymers; D012709:Serum Albumin; D012826:Silicone Elastomers; D019096:Vitronectin